Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial
Overview
This paper presents an economic evaluation comparing metacognitive therapy plus usual care against usual care alone for cardiac rehabilitation participants with anxiety or depression symptoms. The analysis, based on a UK randomized controlled trial of 332 patients, assesses cost-effectiveness over a 12-month period using quality-adjusted life-years as the primary outcome. The results indicate that the intervention may be dominant and cost-saving, though the authors note high uncertainty in these estimates.
- ID
ce2d57ee7bfd4878- Source org
- PubMed Central
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.1136/bmjopen-2024-087414
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:ce2d57ee7bfd4878,
title = {Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial},
journal = {PubMed Central},
doi = {10.1136/bmjopen-2024-087414},
url = {https://doi.org/10.1136/bmjopen-2024-087414}
}RIS
TY - JOUR TI - Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial PB - PubMed Central DO - 10.1136/bmjopen-2024-087414 UR - https://doi.org/10.1136/bmjopen-2024-087414 ER -
APA
Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial. (n.d.). PubMed Central. https://doi.org/10.1136/bmjopen-2024-087414
Related entries
- Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression
- Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
- Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study
- Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease
- Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
- Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial
- Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)
- Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation
- Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study
- Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?